Seminars in Diagnostic Pathology
Volume 27, Issue 1 , Pages 62-68 , February 2010

The origins of early breast carcinoma

  • Tibor Tot, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Tibor Tot, MD, PhD, Department of Pathology and Clinical Cytology, Central Hospital Falun, S791 82 Falun, Sweden

References 

  1. Gallager HS. Treatment selection in primary breast cancer (Pathologic considerations). Am J Roentgenol. 1976;126:135–138
  2. Nealon TF, Nkongho A, Grossi CE, et al. Treatment of early cancer of the breast (T1N0M0 and T2N0M0) on the basis of histologic characteristics. Surgery. 1981;89:279–289
  3. Hartmann WH. Minimal breast cancer (An update). Cancer. 1984;53(suppl 3):681–684
  4. Tabár L, Chen HH, Duffy SW, et al. A novel method for prediction of long-term outcome of women with T1a, T1b and 10-14mm invasive breast cancers: A prospective study. Lancet. 2000;355:429–433
  5. Tabár L, Chen HT, Yen MFA, et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14 mm invasive carcinoma. Cancer. 2004;101:1745–1759
  6. Tot T. The limited prognostic value of measuring and grading small breast carcinomas: The whole sick lobe versus the details within it. Med Sci Monit. 2006;12:RA170–RA175
  7. Llombart-Cussac A. Improving decision-making in early breast cancer: Who to treat and how?. Breast Cancer Res Treat. 2008;112(suppl 1):15–24
  8. Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Cancer. 1985;56:979–990
  9. Faverly DRG, Henricks JHCL, Holland R. Breast carcinoma of limited extent (Frequency, radiologic-pathologic characteristics, and surgical margin requirements). Cancer. 2001;91:647–659
  10. Tot T. The clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histological sections. Cancer. 2007;110:2551–2560
  11. Tot T. The metastastic capacity of multifocal breast carcinomas: Extensive tumors versus tumors of limited extent. Hum Pathol. 2009;40:199–205
  12. Tot T, Pekár Gy, Hofmeyer S, et al. The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential. Virchows Arch. 2009;455:109–115
  13. Dawson FK. Carcinoma in the mammary lobule and its origin. Edinb Med J. 1933;40:57–82
  14. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231–273
  15. Cheatle GL, Cutler M. Tumors of the Breast. London, United Kingdom: Edward Arnoled & CO; 1931;
  16. Azzopardi JG. Problems in Breast Pathology. London, Philadelphia, Toronto: WB Saunders; 1979;pp 104-107
  17. Tot T, Tabár L, Dean PB. Practical Breast Pathology. Stuttgart, New York: Thieme; 2002;
  18. Tabár L, Tot T, Dean PB. Breast Cancer: The Art and Science of Early Detection with Mammography. Stuttgart, New York: Thieme; 2005;
  19. Tot T, Tabár L. Radiologic-pathologic correlation of ductal carcinoma in situ of the breast using two- and three-dimensional large histologic sections. Semin Breast Dis. 2005;8:144–151
  20. Liu S, Ginestier C, Charafe-Jauffret E, et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA. 2008;105:1680–1685
  21. Villadsen R, Fridriksdottir AJ, Ronnov-Jenssen L, et al. Evidence for stem cell hierarchy in the adult human breast. J Cell Biol. 2007;177:87–101
  22. Oakes SR, Hilton HN, Ormandy CJ. The alveolar switch: Coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast Cancer Res. 2006;8:207–216
  23. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111
  24. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983–3988
  25. Lakhani SR, Chaggar R, Davies S, et al. Genetic alterations in “normal” luminal and myoepithelial cells of the breast. J Pathol. 1999;189:496–503
  26. Tsai YC, Lu Y, Nichols PW, et al. Contiguous patches of normal human mammary epithelium derived from a single stem cell: Implications for breast carcinogenesis. Cancer Res. 1996;56:402–404
  27. Heaphy CM, Griffith JK, Bisoffi M. Mammary field cancerization: Molecular evidence and clinical importance. Breast Cancer Res Treat. 2009;118:229–239
  28. Agelopoulos K, Buerger H, Brandt B. Allelic imbalance of the EGFR gene as key event in breast cancer progression—The concept of committed progenitor cells. Curr Cancer Drug Targets. 2008;8:431–445
  29. Tot T. DCIS, cytokeratins and the theory of the sick lobe. Virchows Arch. 2005;447:1–8
  30. Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol. 1994;11:223–235
  31. Fechner RE. Ductal carcinoma involving the lobule of the breast: A source of confusion with lobular carcinoma in situ. Cancer. 1971;28:274–281
  32. Tot T. The theory of the sick lobe and the possible consequences. Int J Surg Pathol. 2007;15:369–375
  33. Foschini MP, Righi A, Cucchi MC, et al. The impact of large sections and 3D technique on the study of lobular in situ and invasive carcinoma of the breast. Virchows Arch. 2006;448:256–261
  34. Foschini MP, Flamminio F, Miglio R, et al. The impact of large sections on the study of in situ and invasive duct carcinoma of the breast. Hum Pathol. 2007;38:1736–1743
  35. Going JJ, Mohun TJ. Human breast duct anatomy, the “sick lobe” hypothesis and intraductal approaches to breast cancer. Breast Cancer Res Treat. 2006;97:285–291
  36. Trichopoulos D. Hypothesis: Does breast cancer originate in utereo?. Lancet. 1990;335:939–940
  37. Xue F, Michels KB. Intrauterine factors and risk of breast cancer: A systemic review and meta-analysis of current evidence. Lancet Oncol. 2007;8:1088–1100

PII: S0740-2570(09)00092-6

doi: 10.1053/j.semdp.2009.12.002

Seminars in Diagnostic Pathology
Volume 27, Issue 1 , Pages 62-68 , February 2010